Trial ID or NCT#

NCT01162018

Status

NOT RECRUITING

Purpose

The proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer diagnosis. The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. PSG data will be collected on the subsample of the population. Data will be gathered via pencil-and-paper measures before, during, immediately following, one month following the completion of treatment and six months after the conclusion of treatment. In addition, actigraphy data (objective sleep continuity data) will be acquired prior to and following treatment

Official Title

Acupuncture for Sleep Disruption in Cancer Survivors

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No

Investigator(s)

David Spiegel, M.D.
Psychiatrist
Jack, Samuel and Lulu Willson Professor in Medicine
Jamie Zeitzer
Oxana Palesh, Ph.D., M.P.H.
Psychologist
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Stanford University Medical Center
Rachel Manber, PhD
Sleep specialist, Pediatric sleep specialist, Psychologist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

David Spiegel
(650) 723-6421